Specific Tumors and Respective Markers
| | | | | Table 8-4 Specific Tumors and Respective Markers | | Entity | | Positive Markers | | Negative Markers | | Atypical fibroxanthoma (AFX) | | Vimentin, actin, + histiocyte stains (i.e., CD68) | | S100, pankeratin, CD34, CEA, EMA, desmin | | Leiomyosarcoma | | Desmin, smooth muscle actin, ± vimentin | | CEA, S100 (only rarely positive), keratin (only rarely positive) | | Melanoma | | S100, vimentin, melanA, HMB45 (latter negative in desmoplastic / spindle cell melanoma) | | Keratin CD45 (also known as leukocyte common antigen or LCA), CEA, EMA, desmin | | Angiosarcoma | | CD31, CD34, Factor VIII–related antigen, Ulex europaeus | | Keratin, CEA, EMA, S100 | | Merkel cell carcinoma (MCC) | | CK 20, EMA, NSE, synaptophysin, chromogranin | | S100, CD45, CEA, vimentin, desmin, GFAP, thyroid transcription factor-1 or TTF-1 | | Schwannoma (Neurilemmoma) | | Vimentin, S100, MBP | | Keratin, neurofilaments, desmin | | Glomus tumor | | Vimentin, smooth muscle actin | | Desmin (occasionally focally positive), cytokeratin | | Epithelioid sarcoma | | Cytokeratin, CD34 (50% cases), EMA, vimentin, ± CEA | | | | DFSP | | Vimentin, CD34 | | S100, HMB45, keratin, stromelysin-3, Factor XIIIa (latter two markers positive in dermatofibroma) | | Paget’s disease | | CK7, EMA, CEA, GCDFP-15 | | S100, HMB45 | | Sebaceous carcinoma | | EMA, keratin (CAM 5.2) | | CEA (usually), S100 | | Granular cell tumor | | S100, NSE, MBP | | GFAP, neurofilament | | | | | | |
| | | | |
|
|